Table 2 Efficacy ranking of nutritional supplements in COPD treatment
Treatment | FEV1% pred (%) | FEV1/FVC (%) | 6MWD (%) | mMRC (%) | CAT (%) | SGRQ (%) |
|---|---|---|---|---|---|---|
Yam-Epimedium | 54.8 | — | 91.0 | 97.4 | — | 99.1 |
coenzyme Q10 + creatine | 37.0 | — | 90.8 | 52.2 | — | — |
beta alanine | — | — | 32.6 | — | — | — |
complex | 42.5 | 28.9 | 42.8 | 45.9 | — | 25.7 |
fish oil | 57.0 | 42.8 | 9.4 | — | — | 46.8 |
Nanocurcumin | 93.0 | 94.5 | — | — | — | — |
MLT | — | — | 80.4 | 89.0 | 99.6 | — |
nitrate | — | 46.7 | 72.8 | 0.00 | 40.5 | 38.8 |
placebo | 37.5 | 45.9 | 31.5 | 48.3 | 12.8 | 6.9 |
pomegranate juice | — | 41.2 | — | — | — | — |
whey proteins | 33.1 | — | 55.4 | 26.9 | 39.2 | — |
butyrate | 65.5 | — | — | — | — | — |
creatine | 42.8 | — | — | — | — | 69.4 |
EAA | — | 62.2 | — | — | — | 47.2 |
probiotic | 83.2 | — | — | — | — | — |
AKL1 | 37.4 | — | 46.0 | 45.0 | — | 65.7 |
V E + V C | — | — | 28.6 | — | — | — |
VD | 42.5 | 57.0 | 18.1 | — | 75.2 | — |
OPC | 21.5 | 40.8 | — | — | — | — |
VC 250 mg | 52.1 | 52.2 | — | — | — | — |
V E 200 mg | 50.4 | 41.3 | — | — | — | — |
VE 400 mg | 49.1 | 45.8 | — | — | — | — |
EPA | — | — | — | 44.8 | 57.9 | — |